FindMyKOL
Clinical trialNCT04880044CompletedInterventional

Detection of Barrett s Esophagus in Patients Without GERD Symptoms

NCT04880044 is an interventional trial sponsored by Case Comprehensive Cancer Center. As of 21 Nov 2026, it is completed. It studies Barrett's Esophagus. The registry lists an enrollment of 132 participants at 1 site in 1 country. The registry lists a start date of 5 Jan 2022 and a primary completion date of 25 Feb 2025. One of its registered investigators has a FindMyKOL profile.

SponsorCase Comprehensive Cancer Center →Enrollment132Barrett's Esophagus
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04880044
FieldValue
Registry IDNCT04880044
StatusCompleted
Study typeInterventional trial
Lead sponsorCase Comprehensive Cancer Center
Enrollment132
Registered sites1
Countries1
ConditionsBarrett's Esophagus
Start5 Jan 2022
Primary completion25 Feb 2025
Study completion25 Feb 2025
Last update posted10 Mar 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to develop a method to detect Barrett's esophagus (BE) in individuals with a new office-based diagnostic test.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04880044

Each answer restates registry values shown on this page.

What is NCT04880044?

NCT04880044 is an interventional trial sponsored by Case Comprehensive Cancer Center. It studies Barrett's Esophagus.

Who leads NCT04880044?

The registry names Amitabh Chak, MD (principal investigator, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center) as the overall official.

Where does NCT04880044 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04880044 end?

The registry lists a primary completion date of 25 Feb 2025 and a study completion date of 25 Feb 2025. The sponsor last updated the record on 10 Mar 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.